ClinicalTrials.Veeva

Menu

Bridging the Gap to Adult Diabetes Care

T

The Hospital for Sick Children

Status

Completed

Conditions

Type1diabetes

Treatments

Behavioral: Data platform +Quality Performance feedback reports

Study type

Interventional

Funder types

Other

Identifiers

NCT03781973
CTO project ID: 1581

Details and patient eligibility

About

Adolescents with type 1 diabetes face particular challenges related to having a chronic illness that requires daily intensive self-management and medical follow-up during a period when their social, developmental, educational, and family situations are in flux. When transitioning from pediatric to adult care, over a third of youth have a care gap of >6 months. During this vulnerable period youth are at risk for acute life-threatening complications such as diabetic ketoacidosis, and for poor glycemic control, which confers an increased risk of chronic diabetes complications. Gaps in care may be a result of deficiencies in transition processes causing some young people to be poorly prepared for adult care and dissatisfied with the transition process. Ineffective transition can lead to decreased frequency of diabetes visits and an increased risk of adverse events in young adulthood. Further, risk factors such as psychiatric comorbidity and behavioural problems in adolescents with type 1 diabetes are associated with poor outcomes in early adulthood. Quality improvement initiatives can be designed to optimize care processes such as referral systems to adult diabetes providers.

Our overall objective is to optimize care and outcomes for youth with diabetes as they transition to adult care.

Specific Aim 1: To improve glycemic control in youth around the time of transition from pediatric to adult diabetes care Specific Aim 2: To evaluate the fidelity and quality of a quality improvement intervention designed to improve transition care processes and to identify contextual factors associated with variation in outcomes.

Enrollment

484 patients

Sex

All

Ages

16 to 19 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All youth with a clinical diagnosis of type 1 diabetes followed at participating centres at the time of their final pediatric clinic visit between Jan 1, 2018 and Dec 31, 2020.
  • Participants will be transitioning to Adult Care (ages ~16-19 yrs).
  • Capacity to read and understand English (we estimate that >95% of participants will fulfill this requirement).
  • Capacity to consent for themselves.

Exclusion criteria

  • Individuals with non-type 1 diabetes.
  • Individuals with type 1 diabetes who move out of Ontario within 12 months after their final pediatric visit.
  • Individuals with type 1 diabetes who do not have the capacity to consent for themselves.

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

484 participants in 3 patient groups

Pre-intervention
No Intervention group
Description:
Those whose last pediatric visit was in the year before the intervention (2018). Medical record data abstracted from patient charts at the time of the final pediatric visit.
Early Intervention
Other group
Description:
Those whose last pediatric visit was in the year immediately after the start of the intervention (2019). The intervention will begin on Jan 1, 2019 and includes the following : 1. Data Platform: Medical record data abstracted from patient charts at the time of the final pediatric visit. . 2. Quality performance feedback reports: We will generate centre-level performance reports. Centres will be able to compare their performance to that of all other centres and to achievable benchmarks. 3. Patient transition experience surveys at the final pediatric visit and 12 months later. 4. Diabetes teams may direct patients and families to online transition resources.
Treatment:
Behavioral: Data platform +Quality Performance feedback reports
Post-Intervention
Other group
Description:
Those whose last pediatric visit was in the second year after the intervention (2020). The intervention includes the following : 1. Data Platform: Medical record data abstracted from patient charts at the time of the final pediatric visit. . 2. Quality performance feedback reports: We will generate centre-level performance reports. Centres will be able to compare their performance to that of all other centres and to achievable benchmarks. 3. Patient transition experience surveys at the final pediatric visit and 12 months later. 4. Diabetes teams may direct patients and families to online transition resources.
Treatment:
Behavioral: Data platform +Quality Performance feedback reports

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems